Follow us on:
Breaking News
February 13th, 2026
CP Direct: Friday Edition
Breaking News

Sanofi Appoints Belén Garijo as CEO

 
Sanofi Appoints Belén Garijo as CEO

Garijo’s priority will be to strengthen the productivity, governance, and innovation capacity of Research & Development.
Read More >>

Top Headlines

Breaking News

Alkermes Acquires Avadel Pharmaceuticals

Accelerates Alkermes’ entry into the sleep medicine market with LUMRYZ.

SPONSOR

Webinar: ADC Payload-Linker CMC Process Development Strategy

Join AsymBio Feb 26 for a CMC roadmap on guidance interpretation, route design, starting materials, stage-based QC and purification process.

Breaking News
Trials & Filings

STADA, Bio-Thera Win EU Clearance for Simponi Biosimilar

European Commission grants approval for Gotenfia, a golimumab biosimilar to Simponi that was developed by Bio-Thera and will be marketed by STADA.

Breaking News

CARsgen to Expand Commercial Manufacturing Base in Shanghai

Signs Strategic Cooperation Agreements with Shanghai Jingong Enterprise.

SPONSOR

Bend Bioscience’s Expanded Vision for Complex Drug Delivery

CEO Owen Murray on driving innovation with high science and high service.

Breaking News
Promotions & Moves

Iterative Health Adds Nadege Gunn as CMO, Hepatology and Obesity

Gunn will provide medical and scientific leadership across metabolic liver disease research and specialized site operations.

Features

The Evolution of Biotech and CDMO Partnerships: A 2026 Outlook

Why agility, scalability, and true collaboration are redefining biotech–CDMO relationships.

SPONSOR

[VIDEO] Overcoming Complexities of Today’s Pharmaceutical Supply Chain

Operational strategies to optimize efficiency and cost effectiveness, and secure an unbroken chain of custody from manufacturing to the end-user.

Featured Resources

Free Basic Listing SPOTLIGHT

Bora Biologics

With a proven track record of over 100 successful cGMP manufacturing batches and the development of more than 42 biologics and biosimilars, Bora Biologics exemplifies how experience drives success. We offer agile, comprehensive end-to-end CDMO solutions that optimize time and cost efficiencies for biopharma companies around the world. We specialize in a diverse range of biologics, including monoclonal antibodies (mAbs), bi-specifics, fusion proteins, recombinant proteins, and enzymes.

 

Solution Center SPOTLIGHT

Quotient Sciences

Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway, from candidate selection through commercial manufacturing. We offer global services for drug substance synthesis and manufacturing, formulation development, clinical trials and clinical & commercial manufacturing.